Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3214181
Max Phase: Preclinical
Molecular Formula: C15H15N3O2
Molecular Weight: 269.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3214181
Max Phase: Preclinical
Molecular Formula: C15H15N3O2
Molecular Weight: 269.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(OCC(=O)N/N=C/c2ccncc2)cc1
Standard InChI: InChI=1S/C15H15N3O2/c1-12-2-4-14(5-3-12)20-11-15(19)18-17-10-13-6-8-16-9-7-13/h2-10H,11H2,1H3,(H,18,19)/b17-10+
Standard InChI Key: WAPVBNMWZLBBNI-LICLKQGHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 269.30 | Molecular Weight (Monoisotopic): 269.1164 | AlogP: 1.92 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.57 | CX Basic pKa: 4.26 | CX LogP: 1.92 | CX LogD: 1.92 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -2.02 |
1. PubChem BioAssay data set, |
Source(1):